nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Pentostatin—hematologic cancer	0.116	0.235	CiPCiCtD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Nelarabine—hematologic cancer	0.116	0.235	CiPCiCtD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Clofarabine—hematologic cancer	0.116	0.235	CiPCiCtD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0875	0.178	CiPCiCtD
Fluorouracil—ABCC3—hematologic cancer	0.0626	0.429	CbGaD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0564	0.115	CiPCiCtD
Fluorouracil—MTHFR—hematologic cancer	0.0397	0.272	CbGaD
Fluorouracil—PPAT—Mercaptopurine—hematologic cancer	0.0319	0.144	CbGbCtD
Fluorouracil—ABCG2—hematologic cancer	0.0304	0.208	CbGaD
Fluorouracil—SLC29A1—Fludarabine—hematologic cancer	0.0203	0.092	CbGbCtD
Fluorouracil—SLC29A1—Cytarabine—hematologic cancer	0.0139	0.0627	CbGbCtD
Fluorouracil—ALB—hematologic cancer	0.0133	0.0909	CbGaD
Fluorouracil—SLC29A1—Mercaptopurine—hematologic cancer	0.0122	0.0551	CbGbCtD
Fluorouracil—ABCC4—Tioguanine—hematologic cancer	0.0108	0.0487	CbGbCtD
Fluorouracil—ABCC5—Mercaptopurine—hematologic cancer	0.00931	0.0421	CbGbCtD
Fluorouracil—SLC29A1—Gemcitabine—hematologic cancer	0.00845	0.0382	CbGbCtD
Fluorouracil—TYMS—Gemcitabine—hematologic cancer	0.00783	0.0354	CbGbCtD
Fluorouracil—ABCG2—Clofarabine—hematologic cancer	0.0053	0.024	CbGbCtD
Fluorouracil—ABCC5—Cisplatin—hematologic cancer	0.00469	0.0212	CbGbCtD
Fluorouracil—ABCC4—Mercaptopurine—hematologic cancer	0.00447	0.0202	CbGbCtD
Fluorouracil—MTHFR—Methotrexate—hematologic cancer	0.00433	0.0196	CbGbCtD
Fluorouracil—TYMS—Methotrexate—hematologic cancer	0.00369	0.0167	CbGbCtD
Fluorouracil—CYP2A6—Methoxsalen—hematologic cancer	0.00369	0.0167	CbGbCtD
Fluorouracil—ABCC3—Vincristine—hematologic cancer	0.00316	0.0143	CbGbCtD
Fluorouracil—CYP1A2—Anagrelide—hematologic cancer	0.00315	0.0142	CbGbCtD
Fluorouracil—ABCG2—Daunorubicin—hematologic cancer	0.00311	0.014	CbGbCtD
Fluorouracil—ABCC3—Cisplatin—hematologic cancer	0.00295	0.0133	CbGbCtD
Fluorouracil—ABCC3—Etoposide—hematologic cancer	0.0029	0.0131	CbGbCtD
Fluorouracil—ABCG2—Teniposide—hematologic cancer	0.0027	0.0122	CbGbCtD
Fluorouracil—CYP2A6—Ifosfamide—hematologic cancer	0.00269	0.0122	CbGbCtD
Fluorouracil—ABCG2—Cladribine—hematologic cancer	0.00259	0.0117	CbGbCtD
Fluorouracil—ABCG2—Imatinib—hematologic cancer	0.00238	0.0108	CbGbCtD
Fluorouracil—ABCG2—Nilotinib—hematologic cancer	0.00216	0.00977	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—hematologic cancer	0.00198	0.00893	CbGbCtD
Fluorouracil—CYP2C9—Bexarotene—hematologic cancer	0.00197	0.0089	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—hematologic cancer	0.00191	0.00865	CbGbCtD
Fluorouracil—ABCG2—Dasatinib—hematologic cancer	0.00191	0.00864	CbGbCtD
Fluorouracil—ABCG2—Mitoxantrone—hematologic cancer	0.00189	0.00853	CbGbCtD
Fluorouracil—CYP2A6—Prednisolone—hematologic cancer	0.00179	0.00811	CbGbCtD
Fluorouracil—CYP2C8—Bortezomib—hematologic cancer	0.00173	0.00782	CbGbCtD
Fluorouracil—CYP1A2—Carmustine—hematologic cancer	0.00166	0.00749	CbGbCtD
Fluorouracil—ALB—Imatinib—hematologic cancer	0.00164	0.00741	CbGbCtD
Fluorouracil—CYP2C9—Idarubicin—hematologic cancer	0.00163	0.00737	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—hematologic cancer	0.0015	0.00677	CbGbCtD
Fluorouracil—ABCG2—Irinotecan—hematologic cancer	0.00149	0.00672	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—hematologic cancer	0.00146	0.00661	CbGbCtD
Fluorouracil—CYP1A2—Methoxsalen—hematologic cancer	0.00141	0.00636	CbGbCtD
Fluorouracil—CYP1A2—Bortezomib—hematologic cancer	0.00134	0.00605	CbGbCtD
Fluorouracil—CYP2C8—Ifosfamide—hematologic cancer	0.00133	0.006	CbGbCtD
Fluorouracil—ABCG2—Vincristine—hematologic cancer	0.0013	0.00587	CbGbCtD
Fluorouracil—CYP1A2—Daunorubicin—hematologic cancer	0.00128	0.00579	CbGbCtD
Fluorouracil—CYP1A2—Alitretinoin—hematologic cancer	0.00125	0.00567	CbGbCtD
Fluorouracil—ABCG2—Cisplatin—hematologic cancer	0.00121	0.00548	CbGbCtD
Fluorouracil—CYP2C9—Bortezomib—hematologic cancer	0.00121	0.00545	CbGbCtD
Fluorouracil—ABCG2—Etoposide—hematologic cancer	0.00119	0.00538	CbGbCtD
Fluorouracil—CYP1A2—Thalidomide—hematologic cancer	0.00117	0.00527	CbGbCtD
Fluorouracil—CYP2C8—Nilotinib—hematologic cancer	0.00115	0.00521	CbGbCtD
Fluorouracil—ALB—Prednisone—hematologic cancer	0.00108	0.00489	CbGbCtD
Fluorouracil—CYP2A6—Dexamethasone—hematologic cancer	0.00106	0.00478	CbGbCtD
Fluorouracil—CYP2C9—Thalidomide—hematologic cancer	0.00105	0.00475	CbGbCtD
Fluorouracil—ALB—Irinotecan—hematologic cancer	0.00102	0.00463	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—hematologic cancer	0.001	0.00454	CbGbCtD
Fluorouracil—CYP2C9—Teniposide—hematologic cancer	0.001	0.00453	CbGbCtD
Fluorouracil—CYP1A2—Imatinib—hematologic cancer	0.000981	0.00444	CbGbCtD
Fluorouracil—ABCG2—Dexamethasone—hematologic cancer	0.000979	0.00442	CbGbCtD
Fluorouracil—UMPS—hematopoietic system—hematologic cancer	0.000973	0.0456	CbGeAlD
Fluorouracil—CYP2C9—Ifosfamide—hematologic cancer	0.000925	0.00418	CbGbCtD
Fluorouracil—CYP2C9—Imatinib—hematologic cancer	0.000884	0.004	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—hematologic cancer	0.000812	0.00367	CbGbCtD
Fluorouracil—CYP2C9—Nilotinib—hematologic cancer	0.000803	0.00363	CbGbCtD
Fluorouracil—CYP1A2—Dasatinib—hematologic cancer	0.000788	0.00356	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—hematologic cancer	0.000787	0.00356	CbGbCtD
Fluorouracil—UMPS—blood—hematologic cancer	0.000644	0.0302	CbGeAlD
Fluorouracil—CYP2C8—Etoposide—hematologic cancer	0.000634	0.00287	CbGbCtD
Fluorouracil—UMPS—bone marrow—hematologic cancer	0.000623	0.0292	CbGeAlD
Fluorouracil—UPP1—blood—hematologic cancer	0.000591	0.0277	CbGeAlD
Fluorouracil—UPP1—bone marrow—hematologic cancer	0.000572	0.0268	CbGeAlD
Fluorouracil—UMPS—lung—hematologic cancer	0.000565	0.0265	CbGeAlD
Fluorouracil—ALB—Methotrexate—hematologic cancer	0.000542	0.00245	CbGbCtD
Fluorouracil—UMPS—testis—hematologic cancer	0.000533	0.025	CbGeAlD
Fluorouracil—CYP2C8—Dexamethasone—hematologic cancer	0.000521	0.00236	CbGbCtD
Fluorouracil—UPP1—lung—hematologic cancer	0.000518	0.0243	CbGeAlD
Fluorouracil—CYP1A2—Etoposide—hematologic cancer	0.000491	0.00222	CbGbCtD
Fluorouracil—UPP1—testis—hematologic cancer	0.000489	0.0229	CbGeAlD
Fluorouracil—DPYD—blood—hematologic cancer	0.00048	0.0225	CbGeAlD
Fluorouracil—PPAT—gonad—hematologic cancer	0.000476	0.0223	CbGeAlD
Fluorouracil—DPYD—bone marrow—hematologic cancer	0.000464	0.0218	CbGeAlD
Fluorouracil—CYP2C9—Cisplatin—hematologic cancer	0.00045	0.00203	CbGbCtD
Fluorouracil—DPYD—lung—hematologic cancer	0.000421	0.0197	CbGeAlD
Fluorouracil—TYMP—hematopoietic system—hematologic cancer	0.00042	0.0197	CbGeAlD
Fluorouracil—PPAT—blood—hematologic cancer	0.000415	0.0195	CbGeAlD
Fluorouracil—PPAT—bone marrow—hematologic cancer	0.000402	0.0188	CbGeAlD
Fluorouracil—DPYD—testis—hematologic cancer	0.000397	0.0186	CbGeAlD
Fluorouracil—MTHFR—hematopoietic system—hematologic cancer	0.000394	0.0185	CbGeAlD
Fluorouracil—UMPS—lymph node—hematologic cancer	0.000386	0.0181	CbGeAlD
Fluorouracil—PPAT—lung—hematologic cancer	0.000364	0.0171	CbGeAlD
Fluorouracil—CYP2C9—Dexamethasone—hematologic cancer	0.000364	0.00164	CbGbCtD
Fluorouracil—TYMS—hematopoietic system—hematologic cancer	0.00036	0.0169	CbGeAlD
Fluorouracil—UPP1—lymph node—hematologic cancer	0.000354	0.0166	CbGeAlD
Fluorouracil—PPAT—testis—hematologic cancer	0.000343	0.0161	CbGeAlD
Fluorouracil—SLC29A1—hematopoietic system—hematologic cancer	0.000323	0.0151	CbGeAlD
Fluorouracil—ABCC3—hematopoietic system—hematologic cancer	0.000295	0.0138	CbGeAlD
Fluorouracil—DPYD—lymph node—hematologic cancer	0.000288	0.0135	CbGeAlD
Fluorouracil—TYMP—blood—hematologic cancer	0.000278	0.013	CbGeAlD
Fluorouracil—TYMS—gonad—hematologic cancer	0.000274	0.0128	CbGeAlD
Fluorouracil—TYMP—bone marrow—hematologic cancer	0.000269	0.0126	CbGeAlD
Fluorouracil—MTHFR—blood—hematologic cancer	0.000261	0.0122	CbGeAlD
Fluorouracil—PPAT—lymph node—hematologic cancer	0.000249	0.0117	CbGeAlD
Fluorouracil—SLC29A1—gonad—hematologic cancer	0.000245	0.0115	CbGeAlD
Fluorouracil—ABCC4—hematopoietic system—hematologic cancer	0.000244	0.0114	CbGeAlD
Fluorouracil—TYMP—lung—hematologic cancer	0.000244	0.0114	CbGeAlD
Fluorouracil—TYMS—blood—hematologic cancer	0.000238	0.0112	CbGeAlD
Fluorouracil—TYMS—bone marrow—hematologic cancer	0.000231	0.0108	CbGeAlD
Fluorouracil—TYMP—testis—hematologic cancer	0.00023	0.0108	CbGeAlD
Fluorouracil—SLC22A7—testis—hematologic cancer	0.000229	0.0107	CbGeAlD
Fluorouracil—MTHFR—lung—hematologic cancer	0.000229	0.0107	CbGeAlD
Fluorouracil—ABCC5—bone marrow—hematologic cancer	0.000225	0.0106	CbGeAlD
Fluorouracil—MTHFR—testis—hematologic cancer	0.000216	0.0101	CbGeAlD
Fluorouracil—SLC29A1—blood—hematologic cancer	0.000214	0.01	CbGeAlD
Fluorouracil—TYMS—lung—hematologic cancer	0.000209	0.0098	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—hematologic cancer	0.000207	0.0097	CbGeAlD
Fluorouracil—ABCC5—lung—hematologic cancer	0.000204	0.00957	CbGeAlD
Fluorouracil—TYMS—testis—hematologic cancer	0.000197	0.00924	CbGeAlD
Fluorouracil—ABCC3—blood—hematologic cancer	0.000196	0.00917	CbGeAlD
Fluorouracil—ABCC5—testis—hematologic cancer	0.000193	0.00903	CbGeAlD
Fluorouracil—SLC29A1—lung—hematologic cancer	0.000187	0.00878	CbGeAlD
Fluorouracil—CYP2A6—lung—hematologic cancer	0.000183	0.00858	CbGeAlD
Fluorouracil—CYP2C8—hematopoietic system—hematologic cancer	0.000177	0.00829	CbGeAlD
Fluorouracil—SLC29A1—testis—hematologic cancer	0.000177	0.00829	CbGeAlD
Fluorouracil—ABCC3—lung—hematologic cancer	0.000171	0.00803	CbGeAlD
Fluorouracil—TYMP—lymph node—hematologic cancer	0.000167	0.00781	CbGeAlD
Fluorouracil—CYP1A2—hematopoietic system—hematologic cancer	0.000166	0.00776	CbGeAlD
Fluorouracil—ABCC3—testis—hematologic cancer	0.000162	0.00758	CbGeAlD
Fluorouracil—ABCC4—blood—hematologic cancer	0.000161	0.00757	CbGeAlD
Fluorouracil—CYP2C9—hematopoietic system—hematologic cancer	0.000157	0.00736	CbGeAlD
Fluorouracil—MTHFR—lymph node—hematologic cancer	0.000157	0.00734	CbGeAlD
Fluorouracil—ABCC4—bone marrow—hematologic cancer	0.000156	0.00732	CbGeAlD
Fluorouracil—TYMS—lymph node—hematologic cancer	0.000143	0.0067	CbGeAlD
Fluorouracil—ABCC4—lung—hematologic cancer	0.000142	0.00663	CbGeAlD
Fluorouracil—ABCC5—lymph node—hematologic cancer	0.00014	0.00654	CbGeAlD
Fluorouracil—ALB—testis—hematologic cancer	0.000138	0.00646	CbGeAlD
Fluorouracil—ABCC4—testis—hematologic cancer	0.000134	0.00626	CbGeAlD
Fluorouracil—SLC29A1—lymph node—hematologic cancer	0.000128	0.00601	CbGeAlD
Fluorouracil—ABCC3—lymph node—hematologic cancer	0.000117	0.0055	CbGeAlD
Fluorouracil—CYP2C8—blood—hematologic cancer	0.000117	0.00549	CbGeAlD
Fluorouracil—ABCG2—blood—hematologic cancer	0.000114	0.00534	CbGeAlD
Fluorouracil—ABCG2—bone marrow—hematologic cancer	0.00011	0.00517	CbGeAlD
Fluorouracil—CYP1A2—blood—hematologic cancer	0.00011	0.00514	CbGeAlD
Fluorouracil—UMPS—Epirubicin—Daunorubicin—hematologic cancer	0.000104	0.0827	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Daunorubicin—hematologic cancer	0.000104	0.0827	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Daunorubicin—hematologic cancer	0.000104	0.0827	CbGdCrCtD
Fluorouracil—CYP2C9—blood—hematologic cancer	0.000104	0.00488	CbGeAlD
Fluorouracil—ALB—lymph node—hematologic cancer	0.0001	0.00469	CbGeAlD
Fluorouracil—ABCG2—lung—hematologic cancer	9.99e-05	0.00468	CbGeAlD
Fluorouracil—CYP2C8—testis—hematologic cancer	9.7e-05	0.00454	CbGeAlD
Fluorouracil—ABCC4—lymph node—hematologic cancer	9.68e-05	0.00454	CbGeAlD
Fluorouracil—CYP1A2—lung—hematologic cancer	9.62e-05	0.00451	CbGeAlD
Fluorouracil—ABCG2—testis—hematologic cancer	9.43e-05	0.00442	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Idarubicin—hematologic cancer	7.91e-05	0.0627	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Idarubicin—hematologic cancer	7.91e-05	0.0627	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Idarubicin—hematologic cancer	7.91e-05	0.0627	CbGdCrCtD
Fluorouracil—TYMS—Nilotinib—Imatinib—hematologic cancer	6.96e-05	0.0552	CbGdCrCtD
Fluorouracil—ABCG2—lymph node—hematologic cancer	6.83e-05	0.0032	CbGeAlD
Fluorouracil—TYMS—Vitamin A—Alitretinoin—hematologic cancer	4.2e-05	0.0333	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—hematologic cancer	3.63e-05	0.0288	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—hematologic cancer	3.63e-05	0.0288	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—hematologic cancer	3.63e-05	0.0288	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—hematologic cancer	3.36e-05	0.0266	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—hematologic cancer	3.36e-05	0.0266	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—hematologic cancer	3.36e-05	0.0266	CbGdCrCtD
Fluorouracil—TYMS—Tretinoin—Alitretinoin—hematologic cancer	2.94e-05	0.0233	CbGdCrCtD
Fluorouracil—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	2.94e-05	0.0233	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Teniposide—hematologic cancer	2.93e-05	0.0232	CbGdCrCtD
Fluorouracil—TYMS—Menadione—Thalidomide—hematologic cancer	2.22e-05	0.0176	CbGdCrCtD
Fluorouracil—TYMS—Vincristine—Vinorelbine—hematologic cancer	1.86e-05	0.0148	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vincristine—hematologic cancer	1.74e-05	0.0138	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vinblastine—hematologic cancer	1.74e-05	0.0138	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Etoposide—hematologic cancer	1.74e-05	0.0138	CbGdCrCtD
Fluorouracil—TYMS—Vinblastine—Vinorelbine—hematologic cancer	1.5e-05	0.0119	CbGdCrCtD
Fluorouracil—TYMS—Vincristine—Vinblastine—hematologic cancer	1.49e-05	0.0118	CbGdCrCtD
Fluorouracil—TYMS—Vinblastine—Vincristine—hematologic cancer	1.2e-05	0.0095	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Pentostatin—hematologic cancer	1.14e-05	0.00901	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Clofarabine—hematologic cancer	1.01e-05	0.00803	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Nelarabine—hematologic cancer	9.53e-06	0.00755	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Fludarabine—hematologic cancer	7.44e-06	0.00589	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Cytarabine—hematologic cancer	7.02e-06	0.00556	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Gemcitabine—hematologic cancer	7.02e-06	0.00556	CbGdCrCtD
Fluorouracil—TYMS—Azacitidine—Cladribine—hematologic cancer	6.84e-06	0.00542	CbGdCrCtD
Fluorouracil—Haemorrhage—Epirubicin—hematologic cancer	6.49e-06	8.79e-05	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—hematologic cancer	6.46e-06	8.75e-05	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—hematologic cancer	6.46e-06	8.75e-05	CcSEcCtD
Fluorouracil—Anorexia—Betamethasone—hematologic cancer	6.45e-06	8.74e-05	CcSEcCtD
Fluorouracil—Anorexia—Dexamethasone—hematologic cancer	6.45e-06	8.74e-05	CcSEcCtD
Fluorouracil—Urticaria—Prednisolone—hematologic cancer	6.44e-06	8.73e-05	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—hematologic cancer	6.44e-06	8.73e-05	CcSEcCtD
Fluorouracil—Rash—Vincristine—hematologic cancer	6.4e-06	8.67e-05	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—hematologic cancer	6.4e-06	8.67e-05	CcSEcCtD
Fluorouracil—Pain—Triamcinolone—hematologic cancer	6.38e-06	8.64e-05	CcSEcCtD
Fluorouracil—Headache—Vincristine—hematologic cancer	6.36e-06	8.62e-05	CcSEcCtD
Fluorouracil—Hypotension—Betamethasone—hematologic cancer	6.33e-06	8.57e-05	CcSEcCtD
Fluorouracil—Hypotension—Dexamethasone—hematologic cancer	6.33e-06	8.57e-05	CcSEcCtD
Fluorouracil—Nausea—Carmustine—hematologic cancer	6.32e-06	8.56e-05	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—hematologic cancer	6.31e-06	8.55e-05	CcSEcCtD
Fluorouracil—Vomiting—Irinotecan—hematologic cancer	6.29e-06	8.52e-05	CcSEcCtD
Fluorouracil—Vomiting—Mitoxantrone—hematologic cancer	6.29e-06	8.52e-05	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—hematologic cancer	6.28e-06	8.5e-05	CcSEcCtD
Fluorouracil—Nausea—Alitretinoin—hematologic cancer	6.26e-06	8.48e-05	CcSEcCtD
Fluorouracil—Convulsion—Prednisone—hematologic cancer	6.26e-06	8.48e-05	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—hematologic cancer	6.24e-06	8.46e-05	CcSEcCtD
Fluorouracil—Rash—Mitoxantrone—hematologic cancer	6.23e-06	8.45e-05	CcSEcCtD
Fluorouracil—Rash—Irinotecan—hematologic cancer	6.23e-06	8.45e-05	CcSEcCtD
Fluorouracil—Dermatitis—Irinotecan—hematologic cancer	6.23e-06	8.44e-05	CcSEcCtD
Fluorouracil—Dermatitis—Mitoxantrone—hematologic cancer	6.23e-06	8.44e-05	CcSEcCtD
Fluorouracil—Headache—Mitoxantrone—hematologic cancer	6.19e-06	8.39e-05	CcSEcCtD
Fluorouracil—Headache—Irinotecan—hematologic cancer	6.19e-06	8.39e-05	CcSEcCtD
Fluorouracil—Nausea—Ifosfamide—hematologic cancer	6.19e-06	8.38e-05	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.17e-06	8.36e-05	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.17e-06	8.36e-05	CcSEcCtD
Fluorouracil—Myalgia—Prednisone—hematologic cancer	6.15e-06	8.33e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Triamcinolone—hematologic cancer	6.15e-06	8.33e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Cisplatin—hematologic cancer	6.14e-06	8.32e-05	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—hematologic cancer	6.13e-06	8.3e-05	CcSEcCtD
Fluorouracil—Vomiting—Gemcitabine—hematologic cancer	6.12e-06	8.3e-05	CcSEcCtD
Fluorouracil—Insomnia—Betamethasone—hematologic cancer	6.12e-06	8.3e-05	CcSEcCtD
Fluorouracil—Insomnia—Dexamethasone—hematologic cancer	6.12e-06	8.3e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Dexamethasone—hematologic cancer	6.08e-06	8.24e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Betamethasone—hematologic cancer	6.08e-06	8.24e-05	CcSEcCtD
Fluorouracil—Discomfort—Prednisone—hematologic cancer	6.08e-06	8.23e-05	CcSEcCtD
Fluorouracil—Rash—Gemcitabine—hematologic cancer	6.07e-06	8.23e-05	CcSEcCtD
Fluorouracil—Dermatitis—Gemcitabine—hematologic cancer	6.07e-06	8.22e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—hematologic cancer	6.06e-06	8.21e-05	CcSEcCtD
Fluorouracil—Erythema—Methotrexate—hematologic cancer	6.04e-06	8.18e-05	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—hematologic cancer	6.04e-06	8.18e-05	CcSEcCtD
Fluorouracil—Headache—Gemcitabine—hematologic cancer	6.03e-06	8.18e-05	CcSEcCtD
Fluorouracil—Nausea—Vincristine—hematologic cancer	6.03e-06	8.17e-05	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—hematologic cancer	6.02e-06	8.16e-05	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—hematologic cancer	6e-06	8.14e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisolone—hematologic cancer	5.98e-06	8.1e-05	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—hematologic cancer	5.97e-06	8.1e-05	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—hematologic cancer	5.96e-06	8.07e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Dexamethasone—hematologic cancer	5.96e-06	8.07e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Betamethasone—hematologic cancer	5.96e-06	8.07e-05	CcSEcCtD
Fluorouracil—Urticaria—Triamcinolone—hematologic cancer	5.93e-06	8.03e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Triamcinolone—hematologic cancer	5.9e-06	7.99e-05	CcSEcCtD
Fluorouracil—Oedema—Prednisone—hematologic cancer	5.89e-06	7.99e-05	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisone—hematologic cancer	5.89e-06	7.99e-05	CcSEcCtD
Fluorouracil—Decreased appetite—Dexamethasone—hematologic cancer	5.88e-06	7.97e-05	CcSEcCtD
Fluorouracil—Decreased appetite—Betamethasone—hematologic cancer	5.88e-06	7.97e-05	CcSEcCtD
Fluorouracil—Nausea—Mitoxantrone—hematologic cancer	5.87e-06	7.96e-05	CcSEcCtD
Fluorouracil—Nausea—Irinotecan—hematologic cancer	5.87e-06	7.96e-05	CcSEcCtD
Fluorouracil—Infection—Prednisone—hematologic cancer	5.86e-06	7.94e-05	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.84e-06	7.92e-05	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.84e-06	7.92e-05	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—hematologic cancer	5.82e-06	7.88e-05	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—hematologic cancer	5.8e-06	7.85e-05	CcSEcCtD
Fluorouracil—Pain—Betamethasone—hematologic cancer	5.79e-06	7.84e-05	CcSEcCtD
Fluorouracil—Pain—Dexamethasone—hematologic cancer	5.79e-06	7.84e-05	CcSEcCtD
Fluorouracil—Nervous system disorder—Prednisone—hematologic cancer	5.78e-06	7.83e-05	CcSEcCtD
Fluorouracil—Tachycardia—Prednisone—hematologic cancer	5.75e-06	7.8e-05	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—hematologic cancer	5.73e-06	7.77e-05	CcSEcCtD
Fluorouracil—Nausea—Gemcitabine—hematologic cancer	5.72e-06	7.75e-05	CcSEcCtD
Fluorouracil—Vomiting—Cisplatin—hematologic cancer	5.71e-06	7.73e-05	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—hematologic cancer	5.69e-06	7.71e-05	CcSEcCtD
Fluorouracil—Rash—Cisplatin—hematologic cancer	5.66e-06	7.67e-05	CcSEcCtD
Fluorouracil—Dermatitis—Cisplatin—hematologic cancer	5.66e-06	7.66e-05	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—hematologic cancer	5.65e-06	7.65e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—hematologic cancer	5.63e-06	7.63e-05	CcSEcCtD
Fluorouracil—Anorexia—Prednisone—hematologic cancer	5.62e-06	7.61e-05	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—hematologic cancer	5.58e-06	7.56e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Betamethasone—hematologic cancer	5.58e-06	7.56e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Dexamethasone—hematologic cancer	5.58e-06	7.56e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Triamcinolone—hematologic cancer	5.5e-06	7.45e-05	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—hematologic cancer	5.44e-06	7.37e-05	CcSEcCtD
Fluorouracil—Leukopenia—Methotrexate—hematologic cancer	5.4e-06	7.32e-05	CcSEcCtD
Fluorouracil—Urticaria—Betamethasone—hematologic cancer	5.38e-06	7.29e-05	CcSEcCtD
Fluorouracil—Urticaria—Dexamethasone—hematologic cancer	5.38e-06	7.29e-05	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.37e-06	7.28e-05	CcSEcCtD
Fluorouracil—Dizziness—Prednisolone—hematologic cancer	5.36e-06	7.27e-05	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—hematologic cancer	5.36e-06	7.27e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Dexamethasone—hematologic cancer	5.35e-06	7.25e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Betamethasone—hematologic cancer	5.35e-06	7.25e-05	CcSEcCtD
Fluorouracil—Nausea—Cisplatin—hematologic cancer	5.33e-06	7.23e-05	CcSEcCtD
Fluorouracil—Insomnia—Prednisone—hematologic cancer	5.33e-06	7.22e-05	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—hematologic cancer	5.32e-06	7.21e-05	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—hematologic cancer	5.31e-06	7.19e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisone—hematologic cancer	5.29e-06	7.17e-05	CcSEcCtD
Fluorouracil—Pruritus—Triamcinolone—hematologic cancer	5.28e-06	7.15e-05	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—hematologic cancer	5.23e-06	7.09e-05	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—hematologic cancer	5.23e-06	7.09e-05	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—hematologic cancer	5.23e-06	7.08e-05	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—hematologic cancer	5.22e-06	7.07e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Prednisone—hematologic cancer	5.19e-06	7.03e-05	CcSEcCtD
Fluorouracil—Rash—Etoposide—hematologic cancer	5.19e-06	7.03e-05	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—hematologic cancer	5.18e-06	7.02e-05	CcSEcCtD
Fluorouracil—Headache—Etoposide—hematologic cancer	5.15e-06	6.98e-05	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—hematologic cancer	5.14e-06	6.96e-05	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—hematologic cancer	5.14e-06	6.96e-05	CcSEcCtD
Fluorouracil—Decreased appetite—Prednisone—hematologic cancer	5.12e-06	6.94e-05	CcSEcCtD
Fluorouracil—Rash—Prednisolone—hematologic cancer	5.11e-06	6.93e-05	CcSEcCtD
Fluorouracil—Dermatitis—Prednisolone—hematologic cancer	5.11e-06	6.92e-05	CcSEcCtD
Fluorouracil—Headache—Prednisolone—hematologic cancer	5.08e-06	6.89e-05	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—hematologic cancer	5.08e-06	6.88e-05	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—hematologic cancer	5.06e-06	6.85e-05	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—hematologic cancer	4.97e-06	6.73e-05	CcSEcCtD
Fluorouracil—Dizziness—Triamcinolone—hematologic cancer	4.93e-06	6.68e-05	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—hematologic cancer	4.93e-06	6.68e-05	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—hematologic cancer	4.93e-06	6.67e-05	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—hematologic cancer	4.89e-06	6.63e-05	CcSEcCtD
Fluorouracil—Infection—Methotrexate—hematologic cancer	4.89e-06	6.63e-05	CcSEcCtD
Fluorouracil—Nausea—Etoposide—hematologic cancer	4.89e-06	6.62e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisone—hematologic cancer	4.86e-06	6.58e-05	CcSEcCtD
Fluorouracil—Nervous system disorder—Methotrexate—hematologic cancer	4.83e-06	6.55e-05	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—hematologic cancer	4.83e-06	6.55e-05	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—hematologic cancer	4.82e-06	6.54e-05	CcSEcCtD
Fluorouracil—Nausea—Prednisolone—hematologic cancer	4.82e-06	6.53e-05	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—hematologic cancer	4.81e-06	6.52e-05	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—hematologic cancer	4.81e-06	6.52e-05	CcSEcCtD
Fluorouracil—Pruritus—Betamethasone—hematologic cancer	4.79e-06	6.49e-05	CcSEcCtD
Fluorouracil—Pruritus—Dexamethasone—hematologic cancer	4.79e-06	6.49e-05	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—hematologic cancer	4.75e-06	6.44e-05	CcSEcCtD
Fluorouracil—Vomiting—Triamcinolone—hematologic cancer	4.74e-06	6.43e-05	CcSEcCtD
Fluorouracil—Rash—Triamcinolone—hematologic cancer	4.7e-06	6.37e-05	CcSEcCtD
Fluorouracil—Dermatitis—Triamcinolone—hematologic cancer	4.7e-06	6.37e-05	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—hematologic cancer	4.7e-06	6.36e-05	CcSEcCtD
Fluorouracil—Urticaria—Prednisone—hematologic cancer	4.68e-06	6.35e-05	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—hematologic cancer	4.68e-06	6.34e-05	CcSEcCtD
Fluorouracil—Headache—Triamcinolone—hematologic cancer	4.67e-06	6.33e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Prednisone—hematologic cancer	4.66e-06	6.31e-05	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—hematologic cancer	4.65e-06	6.3e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Dexamethasone—hematologic cancer	4.63e-06	6.28e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Betamethasone—hematologic cancer	4.63e-06	6.28e-05	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—hematologic cancer	4.61e-06	6.25e-05	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—hematologic cancer	4.61e-06	6.25e-05	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—hematologic cancer	4.6e-06	6.24e-05	CcSEcCtD
Fluorouracil—Infection—Epirubicin—hematologic cancer	4.58e-06	6.21e-05	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—hematologic cancer	4.53e-06	6.14e-05	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—hematologic cancer	4.52e-06	6.13e-05	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—hematologic cancer	4.51e-06	6.12e-05	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—hematologic cancer	4.5e-06	6.1e-05	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.49e-06	6.08e-05	CcSEcCtD
Fluorouracil—Dizziness—Betamethasone—hematologic cancer	4.48e-06	6.07e-05	CcSEcCtD
Fluorouracil—Dizziness—Dexamethasone—hematologic cancer	4.48e-06	6.07e-05	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—hematologic cancer	4.46e-06	6.04e-05	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—hematologic cancer	4.45e-06	6.03e-05	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—hematologic cancer	4.45e-06	6.03e-05	CcSEcCtD
Fluorouracil—Nausea—Triamcinolone—hematologic cancer	4.43e-06	6e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—hematologic cancer	4.42e-06	5.99e-05	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—hematologic cancer	4.4e-06	5.96e-05	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—hematologic cancer	4.39e-06	5.95e-05	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—hematologic cancer	4.39e-06	5.95e-05	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—hematologic cancer	4.38e-06	5.93e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisone—hematologic cancer	4.34e-06	5.88e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—hematologic cancer	4.34e-06	5.88e-05	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	4.32e-06	0.00343	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	4.32e-06	0.00343	CbGdCrCtD
Fluorouracil—Hypotension—Epirubicin—hematologic cancer	4.31e-06	5.84e-05	CcSEcCtD
Fluorouracil—Vomiting—Dexamethasone—hematologic cancer	4.3e-06	5.83e-05	CcSEcCtD
Fluorouracil—Vomiting—Betamethasone—hematologic cancer	4.3e-06	5.83e-05	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—hematologic cancer	4.3e-06	5.83e-05	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—hematologic cancer	4.28e-06	5.8e-05	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Betamethasone—hematologic cancer	4.27e-06	0.00338	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Dexamethasone—hematologic cancer	4.27e-06	0.00338	CbGdCrCtD
Fluorouracil—Rash—Betamethasone—hematologic cancer	4.27e-06	5.78e-05	CcSEcCtD
Fluorouracil—Rash—Dexamethasone—hematologic cancer	4.27e-06	5.78e-05	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—hematologic cancer	4.27e-06	5.78e-05	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—hematologic cancer	4.27e-06	5.78e-05	CcSEcCtD
Fluorouracil—Dermatitis—Betamethasone—hematologic cancer	4.26e-06	5.78e-05	CcSEcCtD
Fluorouracil—Dermatitis—Dexamethasone—hematologic cancer	4.26e-06	5.78e-05	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.25e-06	5.76e-05	CcSEcCtD
Fluorouracil—Headache—Dexamethasone—hematologic cancer	4.24e-06	5.75e-05	CcSEcCtD
Fluorouracil—Headache—Betamethasone—hematologic cancer	4.24e-06	5.75e-05	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—hematologic cancer	4.24e-06	5.74e-05	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	4.23e-06	0.00335	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Betamethasone—hematologic cancer	4.22e-06	0.00335	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	4.22e-06	0.00335	CbGdCrCtD
Fluorouracil—Pain—Methotrexate—hematologic cancer	4.21e-06	5.71e-05	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.2e-06	5.69e-05	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—hematologic cancer	4.18e-06	5.67e-05	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—hematologic cancer	4.18e-06	5.66e-05	CcSEcCtD
Fluorouracil—Pruritus—Prednisone—hematologic cancer	4.17e-06	5.65e-05	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Triamcinolone—hematologic cancer	4.17e-06	0.0033	CbGdCrCtD
Fluorouracil—Insomnia—Epirubicin—hematologic cancer	4.17e-06	5.65e-05	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—hematologic cancer	4.16e-06	5.64e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—hematologic cancer	4.14e-06	5.61e-05	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	4.12e-06	0.00326	CbGdCrCtD
Fluorouracil—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	4.12e-06	0.00326	CbGdCrCtD
Fluorouracil—Dyspnoea—Epirubicin—hematologic cancer	4.11e-06	5.57e-05	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—hematologic cancer	4.1e-06	5.55e-05	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—hematologic cancer	4.07e-06	5.51e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—hematologic cancer	4.06e-06	5.5e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—hematologic cancer	4.06e-06	5.5e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Prednisone—hematologic cancer	4.03e-06	5.47e-05	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.03e-06	0.00319	CbGdCrCtD
Fluorouracil—Nausea—Dexamethasone—hematologic cancer	4.02e-06	5.45e-05	CcSEcCtD
Fluorouracil—Nausea—Betamethasone—hematologic cancer	4.02e-06	5.45e-05	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	4.01e-06	0.00318	CbGdCrCtD
Fluorouracil—Decreased appetite—Epirubicin—hematologic cancer	4.01e-06	5.43e-05	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—hematologic cancer	3.99e-06	5.4e-05	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.98e-06	5.39e-05	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisone—hematologic cancer	3.96e-06	0.00314	CbGdCrCtD
Fluorouracil—Pain—Epirubicin—hematologic cancer	3.94e-06	5.34e-05	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisone—hematologic cancer	3.92e-06	0.0031	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	3.91e-06	0.0031	CbGdCrCtD
Fluorouracil—Urticaria—Methotrexate—hematologic cancer	3.91e-06	5.3e-05	CcSEcCtD
Fluorouracil—Dizziness—Prednisone—hematologic cancer	3.9e-06	5.28e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—hematologic cancer	3.89e-06	5.28e-05	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Betamethasone—hematologic cancer	3.89e-06	0.00309	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Dexamethasone—hematologic cancer	3.89e-06	0.00309	CbGdCrCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.89e-06	5.27e-05	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisolone—hematologic cancer	3.86e-06	0.00306	CbGdCrCtD
Fluorouracil—Insomnia—Doxorubicin—hematologic cancer	3.86e-06	5.23e-05	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—hematologic cancer	3.83e-06	5.19e-05	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisolone—hematologic cancer	3.82e-06	0.00303	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Triamcinolone—hematologic cancer	3.8e-06	0.00301	CbGdCrCtD
Fluorouracil—Dyspnoea—Doxorubicin—hematologic cancer	3.8e-06	5.15e-05	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—hematologic cancer	3.8e-06	5.15e-05	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—hematologic cancer	3.79e-06	5.14e-05	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—hematologic cancer	3.76e-06	5.09e-05	CcSEcCtD
Fluorouracil—Vomiting—Prednisone—hematologic cancer	3.75e-06	5.08e-05	CcSEcCtD
Fluorouracil—Rash—Prednisone—hematologic cancer	3.72e-06	5.04e-05	CcSEcCtD
Fluorouracil—Dermatitis—Prednisone—hematologic cancer	3.71e-06	5.03e-05	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—hematologic cancer	3.71e-06	5.02e-05	CcSEcCtD
Fluorouracil—Headache—Prednisone—hematologic cancer	3.69e-06	5e-05	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.68e-06	4.99e-05	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—hematologic cancer	3.66e-06	4.96e-05	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—hematologic cancer	3.65e-06	4.94e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—hematologic cancer	3.64e-06	4.94e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—hematologic cancer	3.63e-06	4.92e-05	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisone—hematologic cancer	3.61e-06	0.00286	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Prednisolone—hematologic cancer	3.52e-06	0.00279	CbGdCrCtD
Fluorouracil—Feeling abnormal—Doxorubicin—hematologic cancer	3.52e-06	4.76e-05	CcSEcCtD
Fluorouracil—Nausea—Prednisone—hematologic cancer	3.5e-06	4.74e-05	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—hematologic cancer	3.49e-06	4.72e-05	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Betamethasone—hematologic cancer	3.41e-06	0.0027	CbGdCrCtD
Fluorouracil—TYMS—Budesonide—Dexamethasone—hematologic cancer	3.41e-06	0.0027	CbGdCrCtD
Fluorouracil—Hypersensitivity—Epirubicin—hematologic cancer	3.4e-06	4.6e-05	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—hematologic cancer	3.39e-06	4.59e-05	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—hematologic cancer	3.37e-06	4.57e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Methotrexate—hematologic cancer	3.37e-06	4.57e-05	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Triamcinolone—hematologic cancer	3.34e-06	0.00264	CbGdCrCtD
Fluorouracil—Pruritus—Epirubicin—hematologic cancer	3.26e-06	4.42e-05	CcSEcCtD
Fluorouracil—Dizziness—Methotrexate—hematologic cancer	3.26e-06	4.41e-05	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisone—hematologic cancer	3.17e-06	0.00251	CbGdCrCtD
Fluorouracil—Diarrhoea—Epirubicin—hematologic cancer	3.15e-06	4.27e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—hematologic cancer	3.14e-06	4.26e-05	CcSEcCtD
Fluorouracil—Vomiting—Methotrexate—hematologic cancer	3.13e-06	4.24e-05	CcSEcCtD
Fluorouracil—Rash—Methotrexate—hematologic cancer	3.11e-06	4.21e-05	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—hematologic cancer	3.1e-06	4.2e-05	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisolone—hematologic cancer	3.09e-06	0.00245	CbGdCrCtD
Fluorouracil—Headache—Methotrexate—hematologic cancer	3.09e-06	4.18e-05	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—hematologic cancer	3.05e-06	4.13e-05	CcSEcCtD
Fluorouracil—TYMS—Danazol—Prednisone—hematologic cancer	3.03e-06	0.0024	CbGdCrCtD
Fluorouracil—Pruritus—Doxorubicin—hematologic cancer	3.02e-06	4.09e-05	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—hematologic cancer	2.93e-06	3.97e-05	CcSEcCtD
Fluorouracil—Nausea—Methotrexate—hematologic cancer	2.93e-06	3.97e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—hematologic cancer	2.92e-06	3.95e-05	CcSEcCtD
Fluorouracil—Rash—Epirubicin—hematologic cancer	2.91e-06	3.94e-05	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—hematologic cancer	2.9e-06	3.94e-05	CcSEcCtD
Fluorouracil—Headache—Epirubicin—hematologic cancer	2.89e-06	3.91e-05	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—hematologic cancer	2.82e-06	3.82e-05	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—hematologic cancer	2.74e-06	3.71e-05	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—hematologic cancer	2.71e-06	3.68e-05	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—hematologic cancer	2.69e-06	3.64e-05	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—hematologic cancer	2.69e-06	3.64e-05	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—hematologic cancer	2.67e-06	3.62e-05	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—hematologic cancer	2.53e-06	3.43e-05	CcSEcCtD
Fluorouracil—CYP2C8—Metabolism—NUP214—hematologic cancer	8.76e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NUP214—hematologic cancer	8.71e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.67e-07	1.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—IDH1—hematologic cancer	8.67e-07	1.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—hematologic cancer	8.66e-07	1.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—hematologic cancer	8.64e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—hematologic cancer	8.63e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.62e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMMR—hematologic cancer	8.61e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—IDH2—hematologic cancer	8.61e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCG2—hematologic cancer	8.58e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTR—hematologic cancer	8.58e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	8.58e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.57e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TXN—hematologic cancer	8.57e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.57e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—hematologic cancer	8.54e-07	1.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCG2—hematologic cancer	8.54e-07	1.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTR—hematologic cancer	8.54e-07	1.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO2—hematologic cancer	8.42e-07	1.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.39e-07	1.83e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTM1—hematologic cancer	8.38e-07	1.83e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NCOR1—hematologic cancer	8.38e-07	1.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO2—hematologic cancer	8.37e-07	1.82e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CREBBP—hematologic cancer	8.37e-07	1.82e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CB—hematologic cancer	8.36e-07	1.82e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CD—hematologic cancer	8.33e-07	1.81e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—hematologic cancer	8.29e-07	1.81e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK3—hematologic cancer	8.27e-07	1.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTT1—hematologic cancer	8.17e-07	1.78e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—hematologic cancer	8.13e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.12e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTT1—hematologic cancer	8.12e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—hematologic cancer	8.11e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.1e-07	1.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.06e-07	1.76e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—hematologic cancer	8.04e-07	1.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.04e-07	1.75e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—hematologic cancer	8.02e-07	1.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.99e-07	1.74e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—hematologic cancer	7.99e-07	1.74e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SDC1—hematologic cancer	7.98e-07	1.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SDC1—hematologic cancer	7.94e-07	1.73e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—hematologic cancer	7.93e-07	1.73e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA9—hematologic cancer	7.88e-07	1.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ACP5—hematologic cancer	7.88e-07	1.72e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3R1—hematologic cancer	7.86e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—hematologic cancer	7.84e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—hematologic cancer	7.84e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.84e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.84e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—hematologic cancer	7.83e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.78e-07	1.69e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—EP300—hematologic cancer	7.73e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—JAK2—hematologic cancer	7.64e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.64e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.62e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—hematologic cancer	7.61e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NCOR1—hematologic cancer	7.61e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.6e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.58e-07	1.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.53e-07	1.64e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3R1—hematologic cancer	7.49e-07	1.63e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—hematologic cancer	7.43e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—IDH1—hematologic cancer	7.41e-07	1.61e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—hematologic cancer	7.41e-07	1.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NUP98—hematologic cancer	7.4e-07	1.61e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.32e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.32e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TXN—hematologic cancer	7.32e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—hematologic cancer	7.26e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—hematologic cancer	7.26e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—hematologic cancer	7.22e-07	1.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.2e-07	1.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.18e-07	1.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.18e-07	1.56e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.17e-07	1.56e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.16e-07	1.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NUP214—hematologic cancer	7.13e-07	1.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.06e-07	1.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	7.01e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.99e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTR—hematologic cancer	6.99e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—hematologic cancer	6.95e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—hematologic cancer	6.92e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.89e-07	1.5e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—hematologic cancer	6.89e-07	1.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—hematologic cancer	6.85e-07	1.49e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—hematologic cancer	6.83e-07	1.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NQO1—hematologic cancer	6.79e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CD44—hematologic cancer	6.79e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NQO1—hematologic cancer	6.75e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CD44—hematologic cancer	6.75e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—hematologic cancer	6.73e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.7e-07	1.46e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.7e-07	1.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—hematologic cancer	6.67e-07	1.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.65e-07	1.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.64e-07	1.45e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.61e-07	1.44e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—hematologic cancer	6.57e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.54e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.53e-07	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SDC1—hematologic cancer	6.5e-07	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYCS—hematologic cancer	6.42e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—hematologic cancer	6.41e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYCS—hematologic cancer	6.38e-07	1.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.38e-07	1.39e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HSP90AA1—hematologic cancer	6.34e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NUP98—hematologic cancer	6.32e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—hematologic cancer	6.32e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—hematologic cancer	6.22e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.2e-07	1.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.14e-07	1.34e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.14e-07	1.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.13e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NUP214—hematologic cancer	6.09e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—hematologic cancer	6.05e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.03e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—hematologic cancer	5.98e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—hematologic cancer	5.98e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTR—hematologic cancer	5.97e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.97e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.86e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—hematologic cancer	5.86e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—hematologic cancer	5.82e-07	1.27e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CREBBP—hematologic cancer	5.77e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.74e-07	1.25e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—hematologic cancer	5.72e-07	1.25e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.71e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—hematologic cancer	5.7e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.68e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—hematologic cancer	5.66e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.66e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—hematologic cancer	5.65e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—hematologic cancer	5.63e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—hematologic cancer	5.59e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.59e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—hematologic cancer	5.58e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SDC1—hematologic cancer	5.55e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NQO1—hematologic cancer	5.52e-07	1.2e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CD44—hematologic cancer	5.52e-07	1.2e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.48e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—hematologic cancer	5.47e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.44e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.41e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—hematologic cancer	5.4e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—hematologic cancer	5.37e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—hematologic cancer	5.36e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.36e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—hematologic cancer	5.33e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.3e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CREBBP—hematologic cancer	5.24e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.23e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYCS—hematologic cancer	5.23e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.2e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.2e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—hematologic cancer	5.2e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.19e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—hematologic cancer	5.17e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOR1—hematologic cancer	5.17e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3R1—hematologic cancer	5.17e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—hematologic cancer	5.09e-07	1.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.01e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—hematologic cancer	4.97e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—hematologic cancer	4.91e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—hematologic cancer	4.82e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—hematologic cancer	4.77e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NQO1—hematologic cancer	4.72e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CD44—hematologic cancer	4.72e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3R1—hematologic cancer	4.69e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.67e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—hematologic cancer	4.67e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.62e-07	1.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.61e-07	1e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.6e-07	1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—hematologic cancer	4.57e-07	9.96e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYCS—hematologic cancer	4.47e-07	9.73e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.46e-07	9.71e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.44e-07	9.67e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—hematologic cancer	4.42e-07	9.64e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.36e-07	9.5e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—hematologic cancer	4.33e-07	9.44e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—hematologic cancer	4.28e-07	9.32e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.23e-07	9.22e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.23e-07	9.22e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—hematologic cancer	4.22e-07	9.18e-06	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—hematologic cancer	4.16e-07	9.06e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—hematologic cancer	4.12e-07	8.98e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—hematologic cancer	4.09e-07	8.92e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.05e-07	8.82e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.03e-07	8.77e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.99e-07	8.7e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.94e-07	8.58e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—hematologic cancer	3.93e-07	8.56e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.86e-07	8.41e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—hematologic cancer	3.84e-07	8.37e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.81e-07	8.3e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—hematologic cancer	3.74e-07	8.16e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.74e-07	8.15e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.73e-07	8.12e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.62e-07	7.88e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.62e-07	7.88e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—hematologic cancer	3.61e-07	7.87e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.58e-07	7.8e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—hematologic cancer	3.57e-07	7.78e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CREBBP—hematologic cancer	3.56e-07	7.76e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—hematologic cancer	3.44e-07	7.5e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.4e-07	7.4e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—hematologic cancer	3.38e-07	7.35e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—hematologic cancer	3.35e-07	7.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.3e-07	7.18e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.21e-07	6.98e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.2e-07	6.96e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3R1—hematologic cancer	3.19e-07	6.94e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.14e-07	6.85e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.96e-07	6.45e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—hematologic cancer	2.94e-07	6.41e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.91e-07	6.35e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—hematologic cancer	2.91e-07	6.33e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.82e-07	6.14e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.76e-07	6.02e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—hematologic cancer	2.73e-07	5.94e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.69e-07	5.85e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.64e-07	5.75e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.61e-07	5.68e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—hematologic cancer	2.56e-07	5.57e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—hematologic cancer	2.54e-07	5.54e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.49e-07	5.43e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—hematologic cancer	2.44e-07	5.31e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—hematologic cancer	2.42e-07	5.28e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.41e-07	5.25e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—hematologic cancer	2.37e-07	5.17e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.36e-07	5.14e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—hematologic cancer	2.33e-07	5.08e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.23e-07	4.86e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—hematologic cancer	2.16e-07	4.7e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—hematologic cancer	2.08e-07	4.53e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.06e-07	4.48e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—hematologic cancer	1.98e-07	4.32e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.8e-07	3.93e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—hematologic cancer	1.79e-07	3.91e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—hematologic cancer	1.78e-07	3.87e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—hematologic cancer	1.7e-07	3.69e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—hematologic cancer	1.47e-07	3.21e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.47e-07	3.2e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—hematologic cancer	1.47e-07	3.19e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.25e-07	2.73e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—hematologic cancer	1.2e-07	2.61e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—hematologic cancer	1.02e-07	2.23e-06	CbGpPWpGaD
